Literature DB >> 33843275

Biologically Derived, Three-Dimensional, Embryonic Scaffolds for Long-Term Cardiomyocyte Culture.

Mary G Garry1,2,3, Stefan Kren1,3, Joseph B Wenger1,3, Daniel J Garry1,2,3.   

Abstract

The ability to maintain viable cultures of mature, primary cardiomyocytes is challenging. The lack of viable cardiomyocyte cultures severely limits in vitro biochemical assays, toxicology assays, drug screening assays, and other analyses. Here, we describe a novel three-dimensional (3D) embryonic scaffold, which supports the culture of postnatal day 7 murine cardiomyocytes within the embryonic heart for, at least, 28 days. We have observed that these cardiomyocytes display normal differentiation, protein expression, and function after extended culture. This novel culture system will allow for prolonged treatment of cardiomyocytes in a natural 3D orientation and has the potential for providing a superior tool for the screening of therapeutic compounds.

Entities:  

Keywords:  embryonic scaffold; long-term culture; mature cardiomyocytes

Mesh:

Year:  2021        PMID: 33843275      PMCID: PMC8309393          DOI: 10.1089/scd.2021.0060

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   4.390


  33 in total

1.  Cardiomyocyte DNA synthesis and binucleation during murine development.

Authors:  M H Soonpaa; K K Kim; L Pajak; M Franklin; L J Field
Journal:  Am J Physiol       Date:  1996-11

Review 2.  3D cell culture systems: advantages and applications.

Authors:  Maddaly Ravi; V Paramesh; S R Kaviya; E Anuradha; F D Paul Solomon
Journal:  J Cell Physiol       Date:  2015-01       Impact factor: 6.384

3.  Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development.

Authors:  F Li; X Wang; J M Capasso; A M Gerdes
Journal:  J Mol Cell Cardiol       Date:  1996-08       Impact factor: 5.000

4.  Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies.

Authors:  Mary G Garry; Stefan M Kren; Daniel J Garry
Journal:  J Vis Exp       Date:  2016-11-05       Impact factor: 1.355

5.  Generation of human endothelium in pig embryos deficient in ETV2.

Authors:  Satyabrata Das; Naoko Koyano-Nakagawa; Ohad Gafni; Geunho Maeng; Bhairab N Singh; Tara Rasmussen; Xiaoyan Pan; Kyung-Dal Choi; Daniel Mickelson; Wuming Gong; Pruthvi Pota; Cyprian V Weaver; Stefan Kren; Jacob H Hanna; Demetris Yannopoulos; Mary G Garry; Daniel J Garry
Journal:  Nat Biotechnol       Date:  2020-02-24       Impact factor: 54.908

6.  Existing cardiomyocytes generate cardiomyocytes at a low rate after birth in mice.

Authors:  Shah R Ali; Simon Hippenmeyer; Lily V Saadat; Liqun Luo; Irving L Weissman; Reza Ardehali
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-29       Impact factor: 11.205

Review 7.  A neonatal blueprint for cardiac regeneration.

Authors:  Enzo R Porrello; Eric N Olson
Journal:  Stem Cell Res       Date:  2014-07-09       Impact factor: 2.020

8.  Stem Cell-Derived Cardiomyocytes and Beta-Adrenergic Receptor Blockade in Duchenne Muscular Dystrophy Cardiomyopathy.

Authors:  Forum Kamdar; Satyabrata Das; Wuming Gong; André Klaassen Kamdar; Tatyana A Meyers; Pruthvi Shah; James M Ervasti; DeWayne Townsend; Timothy J Kamp; Joseph C Wu; Mary G Garry; Jianyi Zhang; Daniel J Garry
Journal:  J Am Coll Cardiol       Date:  2020-03-17       Impact factor: 27.203

9.  Enhancement of human iPSC-derived cardiomyocyte maturation by chemical conditioning in a 3D environment.

Authors:  Chen Yu Huang; Rebeca Peres Moreno Maia-Joca; Chin Siang Ong; Ijala Wilson; Deborah DiSilvestre; Gordon F Tomaselli; Daniel H Reich
Journal:  J Mol Cell Cardiol       Date:  2019-10-23       Impact factor: 5.000

10.  Advanced maturation of human cardiac tissue grown from pluripotent stem cells.

Authors:  Kacey Ronaldson-Bouchard; Stephen P Ma; Keith Yeager; Timothy Chen; LouJin Song; Dario Sirabella; Kumi Morikawa; Diogo Teles; Masayuki Yazawa; Gordana Vunjak-Novakovic
Journal:  Nature       Date:  2018-04-04       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.